
Founder of GLP Winner, providing transparency around GLP-1 providers. Advocate for GLP-1 accessibility, serial tech entrepreneur, and caregiver of 2 dogs and an aging parent.
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 24 | Founded | 2 years ago | Last Issue | a month ago |
| Active | |||||

If you spend any time in health spaces online, you’ve seen it. People are injecting BPC-157 for injuries, MOTS-c for metabolism and GHK-Cu for skin and healing. Some people say these peptides changed their lives. Others say they’re unstudie...
Compounding Pharmacies making GLP-1s come in two flavors. 503A and 503B.
It’s possible some newer 503Bs have never been inspected by ANY regulator.
A lot of people here have considered 503B medication to be safer and worth paying mor...
The FDA published a warning letter to Empower Pharmacy, and it set off alarm bells for compounded GLP-1 access.
The FDA questioned whether some of the compounded GLP-1s Empower produced were sufficiently customized for individual patients....
The FDA published a warning letter to ProRx, a 503B compounding pharmacy specifically mentioning that 503Bs should not be compounding GLP-1s. The letter was just made public, but was initially sent to ProRx on April 7, 2026. They stopped ma...
Apr 30, 2026 - The FDA announced a proposal to remove semaglutide, tirzepatide, and liraglutide from the 503B bulks list. This would prevent 503B pharmacies from compounding GLP-1s. It is important to remember it’s not removed yet, just in...
Subscribers, engagement, traffic and sponsorship for Sabina.
| Subscribers | Engagement | 70 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Founder of GLP Winner which helps compare GLP-1 providers with transparent reviews, sourcing, and pricing. GLP-1 accessibility with news on litigation, policy and information on the Telehealth landscape.
You can find recent issues that have been published by Sabina on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Sabina, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Sabina as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Sabina using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Sabina. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.